| 臺大學術典藏 |
2020-03-05T12:32:57Z |
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas
|
Kuo S.-H.; Chen L.-T.; Yeh K.-H.; Wu M.-S.; Hsu H.-C.; Yeh P.-Y.; TSUI-LIEN MAO; Chen C.-L.; Doong S.-L.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Liau J.-Y.; SHAN-CHI YU; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L. |
| 臺大學術典藏 |
2020-03-05T07:52:41Z |
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment
|
Kuo S.-H.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; KUAN-TING KUO; Yeh P.-Y.; Tzeng Y.-S.; Wang H.-P.; Hsu P.-N.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:46Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; JIA-HUEI TSAI; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Jia-Huei Tsai;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Jeng Y.-M.; JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:43Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Cheng A.-L.; Yeh K.-H.; Chang Y.-L.; Hung J.-S.; Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R. |
| 臺大學術典藏 |
2020-03-05T06:28:40Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:37Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai J.-H.; JAU-YU LIAU; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:31Z |
Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis
|
Guo J.-C.;Chang C.-C.;Yang C.-Y.;Liao B.-C.;Jau-Yu Liau;Chang C.-H.;Yeh K.-H.; Guo J.-C.; Chang C.-C.; Yang C.-Y.; Liao B.-C.; JAU-YU LIAU; Chang C.-H.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-05T06:28:28Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-05T05:51:28Z |
Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma
|
Yeh K.-H.;Huang-Chun Lien;Hsu S.-M.;Cheng A.-L.; Yeh K.-H.; HUANG-CHUN LIEN; Hsu S.-M.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T05:51:25Z |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors
|
Lu Y.-S.; HUANG-CHUN LIEN; Yeh P.-Y.; Yeh K.-H.; Kuo M.-L.; Kuo S.-H.; Cheng A.-L.; Lu Y.-S.;Huang-Chun Lien;Yeh P.-Y.;Yeh K.-H.;Kuo M.-L.;Kuo S.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:53Z |
Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression
|
Kuo S.-H.; Chen L.-T.; Wu M.-S.; Kuo K.-T.; Yeh K.-H.; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; CHUNG-WU LIN; Lin J.-T.; Cheng A.L. |
| 臺大學術典藏 |
2020-03-03T03:36:52Z |
Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma
|
Kuo S.-H.; Yeh P.-Y.; Chen L.-T.; Wu M.-S.; CHUNG-WU LIN; Yeh K.-H.; Tzeng Y.-S.; Chen J.-Y.; Hsu P.-N.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:52Z |
Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment
|
Kuo S.-H.;Chen L.-T.;Wu M.-S.;Chung-Wu Lin;Yeh K.-H.;Kuo K.-T.;Yeh P.-Y.;Tzeng Y.-S.;Wang H.-P.;Hsu P.-N.;Lin J.-T.;Cheng A.-L.; Kuo S.-H.; Chen L.-T.; Wu M.-S.; CHUNG-WU LIN; Yeh K.-H.; Kuo K.-T.; Yeh P.-Y.; Tzeng Y.-S.; Wang H.-P.; Hsu P.-N.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:46Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo S.-H.;Cheng A.-L.;Chung-Wu Lin;Hsu C.-H.;Wu M.-S.;Yeh K.-H.;Tzeng Y.-S.;Chen L.-T.; Kuo S.-H.; Cheng A.-L.; CHUNG-WU LIN; Hsu C.-H.; Wu M.-S.; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2020-03-03T03:36:46Z |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma
|
Chen L.-T.; Cheng A.-L.; Tsai H.-J.; Yeh K.-H.; Kuo S.-H.;Weng W.-H.;Chen Z.-H.;Hsu P.-N.;Wu M.-S.;Chung-Wu Lin;Jeng H.-J.;Yeh K.-H.;Tsai H.-J.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Weng W.-H.; Chen Z.-H.; Hsu P.-N.; Wu M.-S.; CHUNG-WU LIN; Jeng H.-J. |
| 臺大學術典藏 |
2020-03-03T03:36:45Z |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; CHUNG-WU LIN; Hsu P.-N.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:44Z |
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance
|
Kuo S.-H.; Chen L.-T.; CHUNG-WU LIN; Wu M.-S.; Hsu P.-N.; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; Wang H.-P.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:43Z |
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; CHUNG-WU LIN; Hsu P.-N.; Hsu C.; Wu M.-S.; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:42Z |
Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Chen L.-T.; CHUNG-WU LIN; Hsu P.-N.; Wu M.-S.; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:41Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.;Yeh K.-H.;Wu M.-S.;Chung-Wu Lin;Wei M.-F.;Liou J.-M.;Wang H.-P.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Yeh K.-H.; Wu M.-S.; CHUNG-WU LIN; Wei M.-F.; Liou J.-M.; Wang H.-P.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:41Z |
The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)
|
Kuo S.-H.;Tsai H.-J.;Chung-Wu Lin;Yeh K.-H.;Lee H.-W.;Wei M.-F.;Shun C.-T.;Wu M.-S.;Hsu P.-N.;Chen L.-T.;Cheng A.-L.; Kuo S.-H.; Tsai H.-J.; CHUNG-WU LIN; Yeh K.-H.; Lee H.-W.; Wei M.-F.; Shun C.-T.; Wu M.-S.; Hsu P.-N.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:41Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
Kuo S.-H.;Chen L.-T.;Chung-Wu Lin;Yeh K.-H.;Shun C.-T.;Tzeng Y.-S.;Liou J.-M.;Wu M.-S.;Hsu P.-N.;Cheng A.-L.; Kuo S.-H.; Chen L.-T.; CHUNG-WU LIN; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; Liou J.-M.; Wu M.-S.; Hsu P.-N.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-03T03:36:40Z |
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Wu M.-S.; Yeh K.-H.; CHUNG-WU LIN; Hsu P.-N.; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:28Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:26Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Liau J.-Y.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H. |
| 臺大學術典藏 |
2020-02-25T05:15:25Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:25Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-24T05:14:09Z |
High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection
|
Liang J.-T.;Huang K.-C.;Hong-Shiee Lai;Lee P.-H.;Cheng Y.-M.;Hsu H.-C.;Cheng A.-L.;Hsu C.-H.;Yeh K.-H.;Wang S.-M.;Tang C.;Chang K.-J.; Liang J.-T.; Huang K.-C.; HONG-SHIEE LAI; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; Chang K.-J. |
| 臺大學術典藏 |
2020-02-24T02:29:11Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; BEEN-REN LIN; Cheng A.-L.; Yeh K.-H.; Chen K.-H.; Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Been-Ren Lin;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer
|
Yeh K.-H.; YU-WEN TIEN; Cheng A.-L.; Kuo S.-H.; Yang S.-H.; Guo J.-C.; Yang S.-H.;Guo J.-C.;Yeh K.-H.;Yu-Wen Tien;Cheng A.-L.;Kuo S.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Cheng A.-L.; Kuo S.-H.; Yeh K.-H.; YU-WEN TIEN; Hsu C.-H.; Hsu C.; Guo J.-C.; Wu H.; Kuo T.-C.; Yang S.-H.; Yang S.-H.;Kuo T.-C.;Wu H.;Guo J.-C.;Hsu C.;Hsu C.-H.;Yu-Wen Tien;Yeh K.-H.;Cheng A.-L.;Kuo S.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; YU-WEN TIEN; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-20T06:53:01Z |
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
|
Kuo S.-H.; YU-WEN TIEN; Cheng A.-L.; Yeh K.-H.; Hsu C.; Guo J.-C.; Yang S.-H.; Yang S.-H.;Guo J.-C.;Hsu C.;Kuo S.-H.;Yu-Wen Tien;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2020-02-18T02:13:01Z |
The Usefulness of Intravascular Ultrasound in Popliteal Artery Entrapment Syndrome
|
Chou H.-H.;I-Hui Wu;Yeh K.-H.;Ko Y.-L.;Huang H.-L.; Chou H.-H.; I-HUI WU; Yeh K.-H.; Ko Y.-L.; Huang H.-L. |
| 臺大學術典藏 |
2020-02-14T02:49:54Z |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; Hsu C.; WEN-FANG CHENG; Lin Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-06T05:22:05Z |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Cheng A.-L.; Yeh K.-H.; WEN-FANG CHENG; Lin Y.-L.; Hsu C.; Hsu C.-H.; Shao Y.-Y.; Lu L.-C.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; WEN-FANG CHENG; Hsu C.; Yeh K.-H.;Cheng A.-L.;Lin Y.-L.;WEN-FANG CHENG;Hsu C.;Hsu C.-H.;Shao Y.-Y.;Lu L.-C.; Lu L.-C.; Shao Y.-Y.; Hsu C.-H. |
| 國立臺灣科技大學 |
2020 |
bleRPC: A plug-and-play RPC framework over BLE
|
Cha, S.-C.;Yeh, K.-H.;Huang, Z.-J. |
| 臺大學術典藏 |
2020 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; MING-SHIANG WU; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 國立成功大學 |
2020 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, H.-J.;Tai, J.J.;Chen, L.-T.;Wu, M.-S.;Yeh, K.-H.;Lin, C.-W.;Wang, T.-E.;Wang, H.-P.;Yu, F.-J.;Liou, J.-M.;Hsiao, C.-F.;Cheng, T.-Y.;Yeh, H.-J.;Ko, C.-W.;Chen, M.-J.;Lo, G.-H.;Hsu, P.-I.;Chang, Chang C.-S.;Hwang, W.-S.;Chuang, S.-S.;Lee, H.-W.;Shun, C.-T.;Chiu, Chiu C.-F.;Wang, Wang W.-M.;Hsieh, C.-Y.;Liu, T.-W.;Lin, J.-T.;Kuo, S.-H.;Cheng, A.-L. |
| 國立成功大學 |
2020 |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
|
Chen, L.-T.;Satoh, T.;Ryu, M.-H.;Chao, Y.;Kato, Kato K.;Chung, H.C.;Chen, J.-S.;Muro, K.;Kang, W.K.;Yeh, K.-H.;Yoshikawa, T.;Oh, S.C.;Bai, L.-Y.;Tamura, Tamura T.;Lee, K.-W.;Hamamoto, Y.;Kim, J.G.;Chin, K.;Oh, D.-Y.;Minashi, K.;Cho, J.Y.;Tsuda, M.;Sameshima, H.;Kang, Y.-K.;Boku, N. |
| 國立成功大學 |
2020 |
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
|
Satoh, T.;Kang, Y.-K.;Chao, Y.;Ryu, M.-H.;Kato, Kato K.;Cheol, Chung H.;Chen, J.-S.;Muro, K.;Ki, Kang W.;Yeh, K.-H.;Yoshikawa, T.;Oh, S.C.;Bai, L.-Y.;Tamura, Tamura T.;Lee, K.-W.;Hamamoto, Y.;Kim, J.G.;Chin, K.;Oh, D.-Y.;Minashi, K.;Cho, J.Y.;Tsuda, M.;Tanimoto, M.;Chen, L.-T.;Boku, N. |
| 國立臺灣科技大學 |
2019 |
Privacy enhancing technologies in the internet of things: Perspectives and challenges
|
Cha, S.-C.;Hsu, T.-Y.;Xiang, Y.;Yeh, K.-H. |
| 臺大學術典藏 |
2019 |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Cheng A.-L.; Tzen K.-Y.; Yeh K.-H.; Hsu F.-M.; Huang P.-M.; Wang H.-P.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; CHIA-HSIEN CHENG; Lee J.-M. |
